Fonte: Applied Cancer Research - Supplement. Nome do evento: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS (QUIMIOTERAPIA), PROLIFERAÇÃO CELULAR, APOPTOSE
ABNT
DOS SANTOS, M. L. et al. Identification of Differentially Expressed Genes Associated with ERBB2 Over-expression in Human Mammary Cells in Response to Docetaxel. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 03 nov. 2024. , 2005APA
Dos Santos, M. L., Bessa, A. S., Perez, D. R. V., Netto, M. M., Soares, F. A., Silva Jr., W. A., & Nagai, M. A. (2005). Identification of Differentially Expressed Genes Associated with ERBB2 Over-expression in Human Mammary Cells in Response to Docetaxel. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.NLM
Dos Santos ML, Bessa AS, Perez DRV, Netto MM, Soares FA, Silva Jr. WA, Nagai MA. Identification of Differentially Expressed Genes Associated with ERBB2 Over-expression in Human Mammary Cells in Response to Docetaxel. Applied Cancer Research - Supplement. 2005 ;( 2): 42.[citado 2024 nov. 03 ]Vancouver
Dos Santos ML, Bessa AS, Perez DRV, Netto MM, Soares FA, Silva Jr. WA, Nagai MA. Identification of Differentially Expressed Genes Associated with ERBB2 Over-expression in Human Mammary Cells in Response to Docetaxel. Applied Cancer Research - Supplement. 2005 ;( 2): 42.[citado 2024 nov. 03 ]